A sudden and substantial drop in prescription opioid dispensing matched by a similar decrease in opioid overdose has been noted within 2 years of the introduction of abuse-deterrent extended- release formulations of oxycodone (multiple brands) along with the removal of propoxyphene (multiple brands), a weak opioid, from the prescription market, new research shows. Read more*
*You can create a free account at Medscape to view this article.
